glp 1 zepbound tirzepatide Zepbound: The newest obesity medication explained by an expert Zepbound Now Available Through Hims

The primary ocular concern with GLP-1 receptor agonists has centered on diabetic retinopathy rather than macular degeneration

Related Reading Tirzepatide Weight Loss Before and After Is Tirzepatide the Same as Mounjaro What is Compounded Tirzepatide Can You Take Tirzepatide While Breastfeeding Is Tirzepatide a Peptide Does Tirzepatide Cause Headaches Does Tirzepatide Cause Hair Loss Does Tirzepatide Make You Tired Does Tirzepatide Burn Fat How Long Does It Take for Tirzepatide to Work A Realistic Tirzepatide Weight Loss Before and After Timeline Quick Takeaways: Tirzepatide Before & After 1 Month: Reduced appetite, steady weight loss of about 3 to 5 pounds on average

Metabolic improvements beyond weight Weight is one number

Updated March 2025

The SUMMIT trial demonstrated tirzepatide reduces heart failure events by 38 percent in patients with obesity-related heart failure with preserved ejection fraction, expanding its indications beyond metabolism

Month 3 6: Consistent Progress Patients experience steady weight reduction of 10-20% of their starting weight